UPDATED May 15, 2024
Discover large cap Norwegian Pharmaceuticals & Biotech companies that are on the OSEAX. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
NYKD | kr14.73 | 8.2% | -43.3% | kr4.8b | kr43.00 | PS33.8x | E-23.3% | n/a | ||
PHO | kr60.20 | 2.0% | 17.3% | kr1.6b | kr86.00 | PE6111.5x | E86.9% | 0% | ||
AZT | kr23.65 | -0.4% | -37.4% | kr1.2b | kr25.00 | PE71.4x | E42.0% | n/a | ||
VISTN | kr22.30 | -1.8% | -0.4% | kr988.9m | n/a | PE17.6x | n/a | 4.5% | ||
HBC | kr2.23 | 6.7% | -29.2% | kr881.0m | n/a | PS4x | n/a | n/a | ||
NAVA | kr33.10 | -0.9% | -13.8% | kr577.0m | kr49.00 | PS1.1x | E39.7% | n/a | ||
BGBIO | kr0.13 | -8.8% | -93.4% | kr488.6m | n/a | PS1380.2x | E-19.9% | n/a | ||
ULTI | kr7.40 | 5.3% | -94.0% | kr254.6m | kr6.50 | PB1x | E28.5% | n/a | ||
LYTIX | kr6.28 | 15.0% | -33.9% | kr251.6m | kr13.00 | PS24.6x | S102.7% | n/a | ||
ABS | kr9.80 | -5.8% | 2.1% | kr248.6m | kr10.00 | PS7.4x | E-6.0% | n/a | ||
TRMED | kr1.02 | -5.2% | n/a | kr238.6m | n/a | PB0.9x | n/a | n/a | ||
NANOV | kr2.00 | -18.3% | -22.2% | kr231.8m | n/a | PB3.6x | n/a | n/a | ||
EXTX | kr7.00 | -1.4% | -39.1% | kr224.6m | n/a | PS50373.2x | n/a | n/a | ||
NORD | kr41.00 | 0% | n/a | kr203.8m | n/a | PE2x | n/a | 0% | ||
PCIB | kr1.73 | 5.2% | -8.7% | kr64.7m | n/a | PS21.6x | n/a | n/a | ||
SOFTX | kr0.099 | -12.0% | -98.7% | kr51.0m | n/a | PS7.3x | n/a | n/a | ||
CRNA | kr2.19 | -1.8% | -88.1% | kr17.8m | kr12.00 | PS144.4x | E92.9% | n/a |